TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $253,000 | -73.9% | 230,000 | -75.5% | 0.64% | -35.2% |
| Q4 2019 | $970,000 | +11.4% | 938,600 | +30.4% | 0.99% | +37.0% |
| Q3 2019 | $871,000 | +38.9% | 720,000 | +89.5% | 0.72% | +21.4% |
| Q2 2019 | $627,000 | -40.1% | 380,000 | +3.4% | 0.60% | -28.3% |
| Q1 2019 | $1,047,000 | +35.8% | 367,379 | +9.1% | 0.83% | -17.3% |
| Q4 2018 | $771,000 | +32.9% | 336,800 | +132.3% | 1.01% | +93.3% |
| Q3 2018 | $580,000 | -14.1% | 145,000 | +7.4% | 0.52% | +0.8% |
| Q2 2018 | $675,000 | +31.1% | 135,000 | +35.0% | 0.52% | -20.7% |
| Q1 2018 | $515,000 | +1.0% | 100,000 | 0.0% | 0.65% | +82.1% |
| Q4 2017 | $510,000 | -5.6% | 100,000 | +11.1% | 0.36% | -39.1% |
| Q2 2017 | $540,000 | -77.9% | 90,000 | -78.0% | 0.59% | -77.5% |
| Q1 2017 | $2,444,000 | +10.4% | 410,000 | +28.1% | 2.62% | +65.7% |
| Q4 2016 | $2,214,000 | – | 320,000 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |